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Background The Lives Saved Tool (LiST) projects the magnitude of mortality
reduction based on baseline coverage, demographic characteristics
and coverage targets. As a validation exercise, we compared neona-
tal, post-neonatal, infant, child and under-5 mortality reductions as
projected by LiST to changes in mortality measured through demo-
graphic surveys in Ghana and Mali as part of a recently completed,
retrospective evaluation of a child survival programme.
Methods Using coverage and other information collected during the evalua-
tion, we modelled the predicted mortality reduction, using logical
assumptions to fill gaps if no data were available. We performed a
sensitivity analysis on several indicators for which we used a proxy,
using the results to examine model sensitivity and readdress our
assumptions.
Results In Ghana, the modelled mortality reductions were within the 95%
confidence boundaries of the measured reduction. In Mali LiST
significantly underestimated the reduction. Several coverage
indicators were found to influence the projection, specifically case
management of serious neonatal illness in both countries and
pneumonia treatment, vitamin A measles treatment and breastfeed-
ing promotion in Mali.
Conclusions We consider LiST to be a useful tool given the limitations of the
available data. Although the model was a good match in Ghana, we
identified several limiting factors with the input data in the Mali
projection. This exercise highlights the importance of continually
improving the availability of sound demographic, epidemiological
and intervention coverage data at district and national levels.
More comparative studies are needed to fully assess the strengths
and weaknesses of LiST.
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The Lives Saved Tool (LiST) can use baseline coverage
data, programme targets and a demographic projec-
tion to model the magnitude of mortality reduction
expected from planned programme activities, as
described earlier in this issue
1. As a validation exer-
cise, we modelled data from a recently completed,
retrospective evaluation of a child survival programme
in West Africa and compared the results with esti-
mates of mortality measured through demographic
surveys as part of the evaluation. Using this
large-scale, ‘real life’ evaluation to validate LiST will
help current and future users understand the
strengths and limitations of mortality-modelling tools.
The United Nations Children’s Fund (UNICEF)
implemented the Accelerated Child Survival and
Development (ACSD) programme in 11 countries
from 2001 to 2005, supported by the Canadian
International Development Agency (CIDA). UNICEF
focused efforts on several ‘high-impact’ countries,
including Benin, Ghana, Mali and Senegal, working
closely with country governments and other partners
to implement ACSD with the ultimate goal of redu-
cing under-5 mortality. Focus districts within these
countries implemented three intervention packages.
The ‘EPIþ’ package included vaccinations, vitamin A
supplementation and distribution of insecticide-
treated nets (ITN). The ‘ANCþ’ package targeted
pregnant women and included improved access to
antenatal care and skilled delivery along with tetanus
vaccination, intermittent preventive treatment of
malaria (IPTp) and supplementation with iron/folate
and postpartum vitamin A supplementation. The
‘IMCIþ’ component included promotion of appropri-
ate infant-feeding practices, iodized salt and improved
sick-child care at facility and community levels,
specifically treatment of diarrhoea, malaria and
pneumonia.
2
UNICEF commissioned the Institute for
International Programs at the Johns Hopkins
University (IIP-JHU) to carry out an external, retro-
spective evaluation of the ACSD programme in the
four ‘high-impact’ countries of Benin, Ghana, Mali
and Senegal. The evaluation design was a
non-randomized, comparative study of changes in
coverage, nutritional status and mortality in the
focus districts and national comparison areas, defined
as the entire country excluding the focus districts and
the major metropolitan areas. The evaluation team,
working with UNICEF and in-country partners, doc-
umented ACSD implementation in the focus districts
and contextual factors in both the focus districts and
nationally. Data on coverage of ACSD interventions,
nutritional status and mortality were collected in both
the ACSD focus districts and the national comparison
areas through demographic surveys. The full method-
ology and results of the evaluation are available
elsewhere.
3
Methods
Data sources
We concentrate on the ACSD focus districts in Ghana
and Mali for this exercise, as more robust information
pertaining to intervention implementation and con-
textual factors was available for these districts. In
Benin, we observed few significant changes in inter-
vention coverage over time;
3 thus, Benin was
excluded from this examination of LiST-projected
mortality reductions based on scale-up of intervention
coverage. The endline survey in Senegal did not yield
mortality estimates of adequate quality and the
results were not used to evaluate the ACSD
programme.
We used baseline and endline coverage and mortal-
ity measured through Demographic Health Surveys
(DHS) in both countries and a Multiple Indicator
Survey (MICS) in Ghana. The baseline and endline
survey coverage indicators were inputted into the
LiST and the projected mortality rates were compared
to the survey endline mortality rates. Table 1 identi-
fies the ACSD focus districts and provides information
on the timing of the household surveys and the pre-
and post-ACSD mortality estimation periods and rates
for Ghana and Mali. Pre-existing survey data were
reanalysed for baseline (pre-ACSD) estimates of cov-
erage. We worked with on-going DHS or MICS to
develop supplemental surveys that over-sampled
households in the ACSD focus districts to collect
and analyse endline (post-ACSD) coverage and two
period estimates (pre- and post-ACSD) of mortality.
Periods for estimation of mortality were based on
country-specific timelines of ACSD implementation,
defined through documentation; the periods differed
in each country. Both pre- and post-ACSD period
mortality rates were retrospectively calculated from
the endline surveys using direct methods from the
full birth history. A detailed explanation of methods
used in the ACSD evaluation is available elsewhere.
3
Inputs and assumptions
We used version 3.44 of LiST.
4 Because the demo-
graphic projections and baseline data pre-loaded into
LiST are national, we first adjusted the projection to
represent the ACSD focus districts using available
data from the 2000 census in Ghana and the 1998
census in Mali. National demographic data were
used where no information was available for the
focus districts. For Ghana, we adjusted the baseline
sex and age population distribution and estimated
migration to represent the Upper East region (UER)
using 2000 census data. This assumes that the pro-
portion of the population living in the UER relative to
the rest of the country has remained stable. The total
fertility rate was adjusted using regional estimates
from the DHS 1988, 1993, 1998 and 2003. For Mali,
we adjusted the baseline age and sex population dis-
tribution and migration to represent the focus
COMPARING LiST-MODELLED TO MEASURED MORTALITY REDUCTIONS IN WEST AFRICA i33districts using projected data from the 1998 census
and adjusting for the proportional population of
these districts. District-level total fertility rates (TFR)
were not available, so we used the national-level esti-
mates, which were similar to the regional TFR (con-
taining the focus districts) estimates reported in the
2006 Mali DHS.
The national under-5 cause-of-death profiles loaded
into LiST are from 2000 to 2003 for Ghana and Mali
based on data from the Child Health Epidemiology
Reference Group (CHERG) estimates.
5 Cause-of-
death data are not readily available sub-nationally
for Mali, thus, we used the national profiles with
the assumption that the cause-of-death patterns in
the focus districts are similar to the national. In
Ghana, we used the national cause-of-death profiles,
which were similar to those reported from the
Navrongo demographic surveillance site (DSS) located
in the UER that conducts verbal autopsies to deter-
mine cause of death.The greatest causes of under-5
mortality for communicable diseases at the Navrongo
DSS were malaria, followed by respiratory infections
and diarrhoea.
6
We entered baseline (pre-ACSD period) neonatal,
infant and under-5 mortality rates, as measured retro-
spectively through the endline surveys, into the model
for both countries (Table 1). Baseline, mid-line (for
Ghana) and endline survey coverage estimates were
also input into the model. Combined, Tables 2 and 3
present the intervention coverage indicators that are
available for input in LiST. Table 2 shows the inter-
ventions for which we had available survey data, the
indicator definition we used in the projection and the
pre- and post-ACSD coverage values. Some coverage
indicators were available in the surveys of both coun-
tries such as vaccination, antenatal care, oral rehydra-
tion salts solution for treatment of diarrhoea and
others. Some indicators were only available in one
of the country surveys. For instance, the Mali DHSs
did not collect information on antibiotic treatment of
suspected pneumonia so we used a proxy indicator,
estimating that one-half of the children taken to a
health facility would receive antibiotics. Other cover-
age indicators are not routinely collected in household
surveys such as treatment of measles with vitamin A
or case management of serious neonatal illnesses. In
these instances, we used the survey data to estimate
coverage of these interventions and the assumptions
are shown on Table 2 as well. Table 3 shows the
indicators that could be inputted in LiST for which
no data were available from the surveys and we
either excluded from the analysis or estimated using
LiST formulas.
Sensitivity analysis
We conducted sensitivity analyses on the indicators
listed in Table 2 for which we did not have the
exact indicator from the survey and instead used a
proxy. These include: complementary feeding—educa-
tion only; complementary feeding—education and
supplementation; full supportive care: case manage-
ment of serious neonatal illness; vitamin A for mea-
sles treatment; breastfeeding promotion and case
Table 1 Summary of the ACSD focus districts, the timing of the household surveys and mortality periods for Ghana
and Mali
Ghana Mali
ACSD focus
districts
Upper East region: consists of Bawku West,
Bawku Municipality, Bolgatanga, Bongo,
Builsa, Garu-Tempane, Kassena-Nankana
and Talensi-Nabdam districts
Banamba and Kolokani in the Koulikoro
region, Niono and Bla in the Segou region,
and Koro and Djenne ´ in the Mopti region
Baseline
survey
1998 DHS (217 households in the focus
districts)
2001 DHS (1581 households in the focus
districts)
Midline survey 2003 DHS (280 households in the focus
districts)
No midline survey available
Endline survey 2007 MICS supplemental; modified to include
a full birth history and oversampled in the
focus districts (3324 households)
2006–7 DHS supplemental; oversampled in
the focus districts (3884 households).
Pre-ACSD mortality rate per 1000 live births (95% CI)
Neonatal 38 (29–48) 65 (55–76)
Infant 59 (48–70) 130 (118–143)
Child 51 (37–64) 149 (130–167)
Under-five 107 (88–126) 260 (241–278)
Time Period July 1998 to December 2001 July 1998 to December 2001
Post-ACSD: mortality rate per 1000 live births (95% CI)
Neonatal 26 (18–35) 42 (34–50)
Infant 53 (41–65) 98 (85–111)
Child 35 (27–43) 110 (95–124)
Under-5 86 (72–100) 197 (178–217)
Time period January 2004 to July 2007 July 2003 to December 2006
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COMPARING LiST-MODELLED TO MEASURED MORTALITY REDUCTIONS IN WEST AFRICA i35management of pneumonia (oral antibiotics). We did
not perform a sensitivity analysis on indicators not
routinely collected through household surveys
(Table 3) such as emergency obstetric practices and
abortion services, or for interventions that were not
yet implemented in these two countries, e.g. zinc
treatment and rotavirus vaccination.
Two scenarios were run for each indicator: a ‘low’
scenario in which coverage did not change from base-
line to endline and a ‘high’ scenario in which cover-
age increased to 100%. For each scenario we changed
only the indicator in question. We considered the
model as being sensitive to a particular indicator if
the range between the low and high scenario differed
by five or more deaths per 1000 births relative to the
original modelled under-5 mortality rate. If we found
that the projection was sensitive to a particular indic-
tor, we then examined why there was model sensitiv-
ity and critically assessed our assumptions.
Results
Table 4 shows the modelled results compared to the
measured reduction in mortality rates. Because we
measured period rather than yearly mortality rates
in the ACSD evaluation, we used the 2005 LiST-pro-
jected mortality rates to compare to the midpoint
from the post-ACSD endline periods. In Ghana LiST
underestimates all mortality categories except
post-neonatal. However, all LiST projections are
within the 95% confidence interval of the measured
mortality reduction and hence are not significantly
different. In Mali, using the 95% confidence intervals,
all mortality categories are significantly underesti-
mated by LiST, except for post-neonatal mortality.
However, the latter is not a significant differ-
ence when assessed against the 95% confidence
interval.
Table 5 shows the results of the sensitivity analysis.
For each indicator we show the difference in the
number of deaths for the under-5 mortality rate
from the original projection for both the ‘low’ and
‘high’ scenarios and the total range. In both Ghana
and Mali, we found the projection to be sensitive to
changes in case management of serious neonatal ill-
nesses. According to the national cause-of-death pro-
files, sepsis pneumonia causes  30% of neonatal
deaths in both Ghana and Mali, and no data were
available on coverage for correct management of
these infections.
Case management of pneumonia in Mali is shown
to be the most sensitive across all the indicators tested
for Mali and Ghana. However, the 100% coverage
used in the sensitivity for the ‘high’ scenario is far
from what is reported by surveys—care-seeking of
28% (baseline) and 31% (endline) in Mali, with
one-half of these values used for pneumonia treat-
ment with antibiotics. To further test this assumption
we increased the endline coverage from one-half to
three-fourth of the pneumonia care-seeking indicator
which resulted in two fewer under-5 deaths—a minor
Table 3 LiST indicators not available from the survey data and not used in the country projections: either estimated using
LiST algorithms or not included in the model
Not available from survey data: estimated using
LiST algorithms
Not included in model
Based on the antenatal care indicator:
a
  Case management during pregnancy
  Syphilis detection and treatment
Based on the institutional delivery indicator:
a
  Antenatal corticosteroids for preterm labour
  Antibiotics for pPRoM
  Essential care for all women and immediate essential
newborn care
  Basic emergency obstetric care (clinic)
  Comprehensive emergency obstetric care
  Neonatal resuscitation (institutional)
Based on the skilled birth attendant indicator:
a
  Clean practices and immediate essential newborn care
(home)
  Folic acid supplementation or fortification
(periconceptual)
  Abortion services
  Calcium supplementation
  Balanced Energy supplementation (maternal)
  Case management of malaria during pregnancy (clinic or
hospital)
  Active management of the 3rd stage of labour
  Kangaroo mother care
  Zinc for prevention
  Rotavirus vaccine
  Pneumococcal vaccine
  Oral antibiotics: case management of severe neonatal
infection
  Injectable antibiotics: case management of severe
neonatal infection
  Zinc for treatment
  Therapeutic feeding
  Neonatal resuscitation (home)
  Antibiotics for dysentery
b
  Hygienic disposal of children’s stools
b
aFormulas available in Supplementary Table 1.
bThese data were not collected at both baseline and endline surveys, therefore they were not included in the projection since the
magnitude of scale-up is not known.
i36 INTERNATIONAL JOURNAL OF EPIDEMIOLOGYdifference. Hence, the difference between the LiST
estimate of under-5 mortality change (21 per 1000
live births) and the lower bound of the measured
mortality confidence interval (43 per 1000 live
births) appears too large to be explained only by
pneumonia treatment impact. At the same time
recent evidence suggests that antibiotics are widely
available in the informal private sector of Mali,
7 so
the impact of pneumonia treatment with antibiotics
may be under-reported for Mali.
Table 4 A comparison of the projection and the measured reduction for neonatal, post-neonatal, infant, child and under-5
mortality rates in Ghana and Mali
Rate (per 1000
live births)
Baseline Endline Difference Significance
Value (R) Standard
error (SE)
R-2SE Rþ2SE
Ghana
Neonatal (NN) 38.4 Measured 26.3 12.1 6.7  1.3 25.5 Inside 95% CI
LiST 35 3.4
Post-neonatal (PNN) 20.4 Measured 26.9  6.4 5.7  17.8 5.0 Inside 95% CI
LiST 17 3.4
Infant (1q0) 58.9 Measured 53.2 5.7 8.9  12.0 23.4 Inside 95% CI
LiST 55 3.9
Child (4q1) 50.9 Measured 34.9 16.0 8.1  0.2 32.2 Inside 95% CI
LiST 42 8.9
Under-5 (5q0) 106.7 Measured 86.2 20.6 12.5  4.3 45.5 Inside 95% CI
LiST 96 10.7
Mali
Neonatal (NN) 65.2 Measured 42.2 23.1 6.8 9.5 36.7 Outside 95% CI
LiST 58 7.2
Post-neonatal (PNN) 65.2 Measured 56.2 8.9 6.2  3.4 21.2 Inside 95% CI
LiST 62 3.2
Infant (1q0) 130.4 Measured 98.4 32.0 9.0 14.0 50.1 Outside 95% CI
LiST 121 9.4
Child (4q1) 148.5 Measured 109.6 38.8 9.3 20.2 57.5 Outside 95% CI
LiST 129 19.5
Under-5 (5q0) 259.5 Measured 197.2 62.3 9.9 42.5 82.0 Outside 95% CI
LiST 239 20.5
Table 5 Sensitivity analysis on indicators estimated from survey data: the number of deaths different compared to the LiST
projection for a ‘low’ scenario in which coverage did not change from baseline to endline and a ‘high’ scenario in which
coverage increased to 100% by each indicator in Mali and Ghana
LiST-projected under-five
mortality rate
Number of deaths different from the LiST-projected under-5 mortality rate
Mali Ghana
239 96
U5MR (No. deaths different) U5MR (No. deaths different)
Indicators Low scenario High scenario Total Low scenario High scenario Total
Complementary feeding–edu-
cation only
N/A
a 240 ( 1) 1 N/A
b N/A
b N/A
b
Complementary feeding–sup-
plementation and
education
N/A
a 236 ( 3) 3 N/A
b N/A
b N/A
b
Full supportive care: case
management of serious
neonatal illnesses
240 (þ1) 230 ( 9) 10 97 (þ1) 89 ( 7) 8
Vitamin A for measles
treatment
240 (þ1) 235 ( 4) 5 96 (0) 95 ( 1) 1
Breastfeeding promotion 237 ( 2) 232 ( 7) 9 96 (0) 94 ( 2) 2
Case management of pneu-
monia (oral antibiotics)
239 (0) 213 ( 26) 26 N/A
c N/A
c N/A
c
N/A, not available.
aNo measured change in complementary feeding coverage.
bSample size too small at baseline.
cCoverage data available from surveys; no assumptions required.
COMPARING LiST-MODELLED TO MEASURED MORTALITY REDUCTIONS IN WEST AFRICA i37In Mali, we also found the projection to be sensitive
to changes in coverage of vitamin A for measles treat-
ment, breastfeeding promotion and case management
of pneumonia (Table 5). Vitamin A for treatment of
measles was also found to be marginally sensitive
with the range between the ‘low’ and ‘high’ scenarios
differing by five deaths per 1000 from the original
projection. However, since the ACSD programme did
not focus on treatment of measles with vitamin A
supplementation, we do not have any additional
information on this intervention in Mali.
Breastfeeding promotion was also found to be a sen-
sitive component of the model in Mail, and we exam-
ined the prevalence of exclusive breastfeeding that
was used as a proxy indicator. As part of the ACSD
evaluation in Mali, we measured a statistically signif-
icant reduction of exclusive breastfeeding coverage
from 44% in 2001 to 28% in 2007 (P<0.001) in the
HIDs.
3 This reduction in breastfeeding is
counter-intuitive and may have resulted from an
imprecise measurement at baseline. However, having
no strong argument to remove the indicator, we left it
in the model.
Discussion
LiST projections of mortality reduction based on
changes in coverage for proven interventions were
within the 95% confidence intervals of the measured
mortality reduction in Ghana, and significantly
underestimated mortality in Mali. Given the limita-
tions of the available input data, we consider the
Ghana projection to be an adequate match to the
measured mortality reduction. This does not hold
true for Mali and there are important limitations
with the input indicators for the Mali projection.
Our assumptions for breastfeeding improvement,
neonatal infection case management, treatment of
measles with vitamin A and antibiotic treatment for
pneumonia in Mali may be underestimating the
actual coverage of these interventions. Pneumonia
treatment had the largest influence on the model
and there is supplemental evidence that antibiotics
are likely more widely available and prescribed than
indicated in the survey-reported care seeking for
pneumonia in Mali. Our documentation in the two
countries also indicates that there was a rapid expan-
sion of first-level health facilities in the focus districts
in Mali during this period, and no similar expansion
in Ghana. Another explanation for this finding may
therefore be that increased access to health facilities
in Mali increased coverage of unmeasured indictors,
relative to Ghana. In the future, LiST users should
consider using health facility surveys along with
household surveys to capture the full spectrum of
child health data that impacts mortality.
We have highlighted the sensitivity of LiST mortality
projections in the case of treatment of pneumonia and
serious neonatal illness, but it also applies to other
indicators, such as diarrhoea and malaria treatment
and nutritional interventions. The primary reason is
that these interventions target illnesses that represent
a high proportion of deaths in Africa. There is also the
issue of accuracy of measurement in household sur-
veys used to input data into the model. Our results
indicate that the LiST projections were highly sensitive
to changes in coverage levels for several interventions
for which coverage was not, and in some cases is not,
measured well in the household surveys that serve as
the major, and sometimes only source of coverage
data in most African countries. For example, accurate
reports of the treatment received by a child depends
on the caretaker’s recognition of the illness and cor-
rect reporting of the medicines provided at home or
by a health care provider. The CHERG is currently
working on improving the measurement of coverage
for these and other proven child survival
interventions.
A further dimension of accuracy is sample size. As
can be seen from the baseline and midline household
surveys for Ghana (Table 1), the sample sizes are
small. Furthermore, the target group of children for
which to assess treatment of some of the most sensi-
tive LiST indicators, such as those on treatment of
pneumonia and diarrhoea, is only a small proportion
of all children. This is because the measurement of
treatment can only be done on those children
under-5 who had this illness in the last 2 weeks, a
period required to reduce the impact of memory recall
errors. Such situations require larger sample sizes in
order to adequately assess changes in coverage
between two points in time for such critical treatment
indicators.
Our findings highlight the importance of continuing
efforts to improve the availability of sound demo-
graphic, epidemiological and intervention coverage
data at district and national levels. With respect to
demographic data, LiST currently uses national-level
projections. We have no reason to expect large differ-
ences between the ACSD focus districts and the coun-
try for fertility or migration patterns. Potentially more
serious are differences in cause-of-death profiles for
children <5 years of age between the focus districts
and the country as a whole and changes in the pro-
files over time, especially with respect to levels of
exposure to Plasmodium falciparum malaria. We
attempted to assess the possible effect of using
national estimates of the proportion of deaths due
to malaria in the two countries by reducing the per-
centage of under-5 deaths due to malaria by half and
examining the impact on the projected mortality
reduction. We found negligible impact on the pro-
jected mortality (less than five deaths per 1000 live
births different from the under-5 projected mortality
rate). Given rapid changes in epidemiology in these
and other countries in Africa due to the scale-up of
malaria prevention,
8,9 it will be important to
periodically update the cause-of-death profiles.
i38 INTERNATIONAL JOURNAL OF EPIDEMIOLOGYGiven this and other validation exercises
10, LiST
does appear to be a useful tool for projecting reduc-
tions in mortality based on changes in coverage.
However, more comparison studies are needed to
fully assess the strengths and weakness of the
model. The quality of LiST projections is determined
by the validity, quality and completeness of the input
data—a limitation shared by all modelling tools. LiST
users must examine and report on all assumptions
made, and work together with countries and pro-
grammes to make informed decisions where
high-quality data are not available.
As countries scale-up activities to reach Millennium
Goal 4 to reduce under-5 mortality, indicators for
tracking progress on high impact interventions need
to be strengthened. Child mortality measures in many
developing countries depend on household surveys,
and these can only report on past mortality levels.
More current data on high impact interventions can
be obtained from the same surveys and these should
greatly facilitate monitoring both changes in such
interventions as well as likely changes in under-5
mortality using LiST.
Supplementary data
Supplementary data are available at IJE online.
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KEY MESSAGES
  LiST is a useful modelling tool, however, the limitations of available input data must be considered.
  Modelled mortality reduction is sensitive to certain indicators, such as management of pneumonia
and neonatal sepsis.
  Continual improvements in demographic, epidemiological and intervention coverage data at national
and district levels are necessary.
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